Advertisement: The ONE Group
RealVNC mid banner careers
2 January, 2019 - 14:50 By Kate Sweeney

Kerr joins Abcam board

Abcam plc, which supplies life science research tools worldwide from its Cambridge HQ, has strengthened the board with the appointment of Giles Kerr as a non-executive director. He has joined the company’s audit and risk committee.

Kerr has extensive experience as an executive and non-executive director in a wide range of public and private organisations. 

He recently stepped down as finance director of Oxford University, a position he had held since 2005. He remains a non-executive director of Arix Biosciences plc, Adaptimmune Therapeutics plc, Senior plc, PayPoint plc as well as Oxford Sciences Innovation.

From 1990 to 2004 Kerr held a number of roles at Amersham plc, including group finance director. He is a graduate in economics from the University of York and a chartered accountant.

Peter Allen, chairman of Abcam said: “Giles brings a wealth of experience within the life science sector, finance and a first-hand understanding of our academic research customers. He will make a valuable contribution to our board.”

Kerr added: “I have known and admired Abcam’s business for many years and am proud to be able to join the team. I look forward to working with the board as the company continues to execute on its strategy and build on its position as global leader.”

Newsletter Subscription

Stay informed of the latest news and features